The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Original Article
PreviousPrevious
Volume 337:453-458 August 14, 1997 Number 7
NextNext

Origin of Nodular Lymphocyte-Predominant Hodgkin's Disease from a Clonal Expansion of Highly Mutated Germinal-Center B Cells
Theresa Marafioti, M.D., Michael Hummel, Ph.D., Ioannis Anagnostopoulos, M.D., Hans-Dieter Foss, M.D., Brunangelo Falini, M.D., Georges Delsol, M.D., Peter G. Isaacson, M.D., Stefano Pileri, M.D., and Harald Stein, M.D.

 

This Article
-Abstract
- PDF

Commentary
-Letters

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
ABSTRACT

Background The atypical cells of nodular lymphocyte-predominant Hodgkin's disease, designated lymphocytic and histiocytic (L&H) cells, have a B-cell phenotype. To clarify the clonality of these cells, we studied rearranged immunoglobulin genes for the variable region of the heavy chain (VH genes) in individual L&H cells from 11 patients with nodular lymphocyte-predominant Hodgkin's disease. We also studied the expression of immunoglobulin light chains by those cells in six of the same patients.

Methods Single CD20+ L&H cells were isolated from frozen sections by a technique of micromanipulation. The rearranged VH genes of these cells were amplified by the polymerase chain reaction (PCR), sequenced, and compared with germ-line VH genes. Immunoglobulin light-chain messenger RNA (mRNA) was detected by in situ hybridization.

Results Of 615 L&H cells isolated from all the frozen sections, 160 yielded PCR products. In each of the 11 patients, the L&H cells that could be evaluated had identically rearranged VH genes, whether they were isolated from the same nodule, different nodules, or different blocks of tissue. All the VH sequences derived from the L&H cells were highly mutated (7.5 to 27.2 percent). In two cases the coding capacity of the VH genes was completely or partially disrupted by mutations. Intraclonal diversity was found in six cases, and monotypic immunoglobulin light-chain mRNA was found in six.

Conclusions The L&H cells of nodular lymphocyte-predominant Hodgkin's disease represent a monoclonal expansion of B cells. The high load of VH gene mutations and signs of intraclonal diversity suggest a relation between L&H cells and germinal-center B cells at the centroblastic stage of differentiation.


Lymphocyte-predominant Hodgkin's disease,1,2,3 an indolent disorder associated with a long survival,4 represents approximately 5 percent of all cases of Hodgkin's disease.5 Its histopathological features include an obliterated lymph-node structure that usually contains small numbers of large, dysplastic cells, designated lymphocytic and histiocytic (L&H) cells, and numerous small lymphocytes. There is a nodular subtype of the disease that occurs frequently and a diffuse subtype that occurs rarely.3 L&H cells have consistently been found to express B-cell markers,6,7,8 but it is unclear whether lymphocyte-predominant Hodgkin's disease is a monoclonal neoplasm or a premalignant or reactive condition with polyclonal L&H cells. Most studies have not found clonal populations of B cells by the analysis of Southern blots or polymerase-chain-reaction (PCR) products of DNA extracts from tissue or single L&H cells that have been isolated,9,10,11,12,13,14,15,16 but some investigators have demonstrated the expression of monotypic immunoglobulin light chains.17,18,19 These conflicting data probably result from technical difficulties. We used an improved method of isolating cells from frozen sections of tissue from 11 patients with typical cases of nodular lymphocyte-predominant Hodgkin's disease and analyzed their VH gene rearrangements. Six of these patients were also studied for immunoglobulin light-chain transcripts by in situ hybridization. The two approaches yielded congruent results: the pattern of rearranged VH genes in the L&H cells indicated a monoclonal population, and the cells expressed only one type of light chain.

Methods

Tissue Samples

We collected frozen specimens of tissue from patients with typical cases of nodular lymphocyte-predominant Hodgkin's disease that met the criteria of the revised European–American lymphoma20 classification. The samples were obtained from files at the institutes of pathology in London; Toulouse, France; Perugia and Bologna, Italy; and Berlin, Germany. Hyperplastic tonsils were used as controls.

Isolation of Single Cells

Seven-micrometer-thick frozen sections were immunostained for CD20 (L26) or the beta chain of the T-cell receptor ({beta}F1). From 25 to 89 CD20+ L&H cells (615 cells in all) and 7 normal T cells (84 in all) were isolated from the frozen tissue from the 11 patients; for 1 patient, two samples obtained nine months apart were studied. In addition, 260 B cells were extracted from two hyperplastic tonsils (158 cells) and seven patients with nodular lymphocyte-predominant Hodgkin's disease (102 cells). In contrast to previous studies of single cells,12,16,21,22 our method involved suspending the isolated cells in a minimal volume of buffer (less than 250 nl). To check for the presence of contaminating VH sequences in the buffer, aliquots of at least 1 µl were drawn after the isolation of each cell (959 aliquots in all). Cells were isolated from each section two to six times, depending on the number of L&H cells that could be amplified.

PCR and Analysis of DNA Sequences

To detect single copies of rearranged VH genes, we used a fully nested PCR with family-specific FW1 primers23 and a consensus JH primer (LJH)24 in the first amplification and modified family-specific FW2 primers in conjunction with a nested JH primer (VLJH) in the second amplification.15,24,25 The isolated PCR products were sequenced, and the number of somatic mutations in the amplified VH region was determined by comparison with corresponding germ-line VH segments. To establish the coding capacity of the L&H cells, the sequences of the amplification products were translated into the amino acids and studied as described elsewhere.25,26

In Situ Hybridization

After the linearization of plasmids containing the immunoglobulin kappa and immunoglobulin lambda light-chain constant regions, antisense and sense transcripts labeled with sulfur-35 were generated with T7 or SP6 RNA polymerases (Promega–Biotech, Madison, Wis.). In situ hybridization was performed as described previously.27

Results

Immunoglobulin VH Rearrangements

Individual CD20+ L&H cells (from 25 to 89 per patient) were isolated from frozen sections of tissue from 11 patients with nodular lymphocyte-predominant Hodgkin's disease and studied by single-copy PCR for rearrangements of the VH genes (Figure 1A and Table 1). From a total of 615 L&H cells and 260 B cells from hyperplastic tonsils as well as patients with nodular lymphocyte-predominant Hodgkin's disease, 160 (26 percent) and 102 (39 percent) amplification products of appropriate size for rearranged VH genes were obtained, respectively. Eighty-four T cells isolated from frozen sections of tissue from the 11 patients (with two samples from Patient 1) did not generate VH amplification products, with one exception (Table 1). Aliquots from the buffer overlying the frozen sections during the process of cell isolation were tested after the selection of each cell, and none of these 959 samples of buffer gave rise to PCR products.



View larger version (148K):
[in this window]
[in a new window]
 
Figure 1. Studies of the Clonal Relation among Eight Lymphocytic and Histiocytic (L&H) Cells Isolated from Patient 11.

Panel A shows a frozen section of a lymph node from the patient after immunostaining for CD20 (alkaline phosphatase–anti-alkaline phosphatase method, x100), with the reaction products staining red. The white zones surrounded by red rims are the spaces formerly occupied by the L&H cells that were isolated from the section by a micropipette. Among these isolated L&H cells, those that gave rise to VH amplification products are indicated (arrows; the numbering is arbitrary and does not correspond to the order in which the cells were isolated). The boxed portion of the section is shown at higher magnification (inset at upper left, x400).

Panel B shows a genealogic tree indicating the somatic mutations in the clonally related VH sequences in the same eight L&H cells, numbered as in Panel A. The germ-line sequence (VH3) and the hypothetical intermediate sequence are also shown. The numbers and positions shown adjacent to the lines indicate the locations of the nucleotide substitutions and their types. The length of the lines corresponds to the number of mutations in the sequence. Uppercase letters denote replacement mutations, and lowercase letters silent mutations. The location numbers follow the system of Cook and Tomlinson.26

 
View this table:
[in this window]
[in a new window]
 
Table 1. Clinical Data and Rearrangements of Immunoglobulin Heavy-Chain Genes in L&H Cells from 11 Patients with Nodular Lymphocyte-Predominant Hodgkin's Disease.

 
By gel electrophoresis and sequence analysis, all but 1 of the 160 VH gene amplification products derived from the L&H cells from the same patient proved to be identical, whether the cells were isolated from the same nodule, different nodules, or different sections of tissue that were analyzed independently. In addition, the two biopsy specimens obtained from Patient 1 nine months apart had identical VH sequences. In contrast, the VH gene rearrangements in all the single B cells from hyperplastic tonsils and patients with nodular lymphocyte-predominant Hodgkin's disease were unrelated to each other, to the rearrangements in the L&H cells, and to sequences from a data bank (GenBank release 98).

Somatic Mutations

The rearranged VH genes of the L&H cells from all 11 patients were found to contain from 11 to 40 nucleotide substitutions (7.5 to 27.2 percent) when they were compared with the corresponding germ-line segments. Most of the mutations were located in complementarity-determining region (CDR) 2 (average mutation rate in CDR2, 21.6 percent), whereas framework region 3 was affected less often (average mutation rate, 8 percent).

Among these clones with hypermutated L&H cells, six had intraclonal diversity (Table 2 and Figure 1B). In the L&H cells from two patients, the coding capacity of the VH genes was disrupted by the mutations. In Patient 4, the VH genes of all 13 L&H cells were silenced by two stop codons and a shift in the reading frame. In Patient 7, the coding capacity was only partly lost, because in 11 of the 13 L&H cells there was a stop codon in framework region 3.

View this table:
[in this window]
[in a new window]
 
Table 2. Molecular Features of the Immunoglobulin Heavy- and Light-Chain Genes in L&H Cells of 11 Patients with Nodular Lymphocyte-Predominant Hodgkin's Disease.

 
Immunoglobulin Light-Chain Transcripts

In 6 of the 11 patients we used in situ hybridization of frozen tissue to study immunoglobulin light-chain transcripts. In all six patients, the L&H cells had moderately strong labeling for immunoglobulin light-chain kappa messenger RNA, but they were not labeled by the immunoglobulin light-chain lambda antisense probes (Table 2). Both probes for immunoglobulin light chains marked plasma cells strongly and marked a proportion of reactive lymphoid cells weakly. Sense probes produced only background signals.

Discussion

It is generally agreed that L&H cells have a B-cell phenotype, but their clonality is controversial. To clarify this issue, we studied the rearranged VH genes in individual L&H cells isolated from frozen sections of tissue from 11 patients with nodular lymphocyte-predominant Hodgkin's disease. We identified the cells morphologically and with the B-cell marker CD20. The L&H cells in each patient had the same rearrangement of VH genes. This finding confirmed that L&H cells were B cells (because only B cells contain rearranged VH genes) and showed that L&H cells arise as a result of clonal expansion. The clonality of these cells was further evidenced by the monotypic expression of immunoglobulin light-chain transcripts, which is in accordance with earlier studies.17,18,19

Previous studies by single-cell PCR of both the nodular lymphocyte-predominant12,16,28 and classic types of Hodgkin's disease have had discordant results.16,22,28 These discrepancies were most likely due to difficulties with the technique of cell isolation, among which problems with the amplification of contaminating VH sequences are the most serious. We overcame this difficulty by reducing the volume of buffer used in the suspension of single cells. With this technical modification, none of the 959 samples that were drawn from the buffer covering the frozen sections after the isolation of each cell contained VH-specific amplification products, and only 1 of the 84 T cells isolated from the tissue sections from the patients with nodular lymphocyte-predominant Hodgkin's disease yielded a PCR product. Moreover, 260 B cells isolated from frozen sections of hyperplastic tonsils and samples of tissue affected by the disease gave rise to 102 PCR products with unrelated VH genes.

The CDR3 sequence is the molecular signature of a B cell, because randomly selected nucleotides are inserted in the course of the VH rearrangement. None of the VH sequences derived from the clonal L&H cells that we studied were homologous with sequences we studied previously or with CDR3 sequences in the data bank. The single VH rearrangement in the sample from Patient 3 that was unrelated to the highly mutated clonal population of L&H cells probably originated from a neighboring B cell, as was evidenced by the absence of somatic mutations in the rearranged VH gene. That two biopsy specimens from Patient 1 obtained nine months apart contained identical VH rearrangements provides further support for the validity of our method.

Physiologically, somatic mutations are introduced into immunoglobulin V genes at the centroblastic stage of B-cell differentiation in germinal centers during the immune response.29,30 Through this process, B cells acquire immunoglobulin receptors with higher or lower affinity for the antigen. The high-affinity B cells are selected by antigen for further differentiation into memory B cells and plasma cells.30 These cells have a low-to-moderate number of somatic mutations (up to 6 percent).29 By contrast, receptors on B cells that have highly mutated V genes lose affinity for the antigen and undergo apoptosis.30 In our study, the high load of somatic mutations (7.5 to 27.2 percent) in all 11 cases of nodular lymphocyte-predominant Hodgkin's disease and the signs of ongoing mutation in 6 of these cases suggest that L&H cells are resistant to these physiologic mechanisms, perhaps because of a block in the apoptotic pathway. The presence in two patients of L&H cells with disrupted capacity for coding by immunoglobulin genes supports this theory, because normally such B cells cannot survive.

The evidence that L&H cells are related to B cells in germinal centers or their progeny includes the pattern of VH gene mutation, the consistent association of L&H cells with progressively transformed germinal centers,31 the distribution of L&H cells within these structures, the expression of cell antigens characteristic of the germinal center,32,33,34 and the resemblance of the L&H cells to large centroblasts. Our findings show that L&H cells arise from a single clone of germinal-center B cells.

Although our data are limited and the light-chain V genes of L&H cells were not sequenced, it appears that the rearranged V genes in L&H cells and those in Reed–Sternberg cells have undergone somatic mutation to a similar extent21 (and this study). However, in L&H cells these mutated genes usually retain the potential for translation into protein, whereas in Reed–Sternberg cells they often lose their coding capacity.21 Moreover, intraclonal variants seem to be more frequent among L&H cells than among Reed–Sternberg cells. If further investigation substantiates these differences, they would constitute important molecular distinctions between nodular lymphocyte-predominant Hodgkin's disease and classic Hodgkin's disease.

Sponsored by a grant (Ste 318/7-1) from the Deutsche Forschungsgemeinschaft, by a grant (M25/89/St1) from the Deutsche Krebshilfe, and by the Italian Association for Cancer Research (Milan).

We are indebted to H. Lammert, C. Kreschel, H. Protz, E. Berg, and H.-H. Müller for their excellent technical assistance; to P. Korbjuhn, M.D., and L. Pasqualucci, M.D., for their scientific contributions; and to J. Yates for her editorial assistance.


Source Information

From the Institute of Pathology, University Hospital Benjamin Franklin, Free University Berlin, and the Consultation and Reference Center for Lymph Node Pathology and Haematopathology, Berlin, Germany (T.M., M.H., I.A., H.-D.F., H.S.); the Institute of Hematology, University of Perugia, Perugia, Italy (B.F.); the Laboratoire Central d'Anatomie–Pathologie, Hôpitaux de Toulouse, Centre Hospitalier Universitaire Purpan, Toulouse, France (G.D.); the Department of Histopathology, University College London Medical School, London (P.G.I.); and the Secondo Servizio di Anatomia Patologica, Sezione di Emolinfopatologia, Università di Bologna, Bologna, Italy (S.P.).

Address reprint requests to Professor Stein at the Institute of Pathology, Benjamin Franklin University Hospital, Free University Berlin, Hindenburgdamm 30, 12200 Berlin, Germany.

References

  1. Lukes RJ, Craver LF, Hall TC, Rappaport H, Ruben P. Report of the Nomenclature Committee. Cancer Res 1966;26:1311-1311. 
  2. Jackson H Jr, Parker F Jr. Hodgkin's disease. I. General considerations. N Engl J Med 1944;230:1-8. 
  3. Lukes RJ, Butler JJ. The pathology and nomenclature of Hodgkin's disease. Cancer Res 1966;26:1063-1083. [Medline]
  4. Regula DP Jr, Hoppe RT, Weiss LM. Nodular and diffuse types of lymphocyte predominance Hodgkin's disease. N Engl J Med 1988;318:214-219. [Abstract]
  5. Colby TV, Hoppe RT, Warnke RA. Hodgkin's disease: a clinicopathologic study of 659 cases. Cancer 1982;49:1848-1858. [CrossRef][Medline]
  6. Stein H, Hansmann ML, Lennert K, Brandtzaeg P, Gatter KC, Mason DY. Reed-Sternberg and Hodgkin cells in lymphocyte-predominant Hodgkin's disease of nodular subtype contain J chain. Am J Clin Pathol 1986;86:292-297. [Medline]
  7. Pinkus GS, Said JW. Hodgkin's disease, lymphocyte predominance type, nodular -- further evidence for a B cell derivation: L & H variants of Reed-Sternberg cells express L26, a pan B cell marker. Am J Pathol 1988;133:211-217. [Abstract]
  8. Korkolopoulou P, Cordell J, Jones M, et al. The expression of the B-cell marker mb-1 (CD79a) in Hodgkin's disease. Histopathology 1994;24:511-515. [Medline]
  9. Angel CA, Pringle JH, Naylor J, West KP, Lauder I. Analysis of antigen receptor genes in Hodgkin's disease. J Clin Pathol 1993;46:337-340. [Free Full Text]
  10. Angel CA, Pringle JH, Primrose L, Lauder I. Detection of immunoglobulin heavy chain gene rearrangements in Hodgkin's disease using PCR. J Clin Pathol 1993;46:940-942. [Free Full Text]
  11. Pan LX, Diss TC, Peng HZ, Norton AJ, Isaacson PG. Nodular lymphocyte predominance Hodgkin's disease: a monoclonal or polyclonal B-cell disorder? Blood 1996;87:2428-2434. [Free Full Text]
  12. Delabie J, Tierens A, Wu G, Weisenburger DD, Chan WC. Lymphocyte predominance Hodgkin's disease: lineage and clonality determination using a single-cell assay. Blood 1994;84:3291-3298. [Free Full Text]
  13. Wickert RS, Weisenburger DD, Tierens A, Greiner TC, Chan WC. Clonal relationship between lymphocytic predominance Hodgkin's disease and concurrent or subsequent large-cell lymphoma of B lineage. Blood 1995;86:2312-2320. [Free Full Text]
  14. Greiner TC, Gascoyne RD, Anderson ME, et al. Nodular lymphocyte-predominant Hodgkin's disease associated with large-cell lymphoma: analysis of Ig gene rearrangements by V-J polymerase chain reaction. Blood 1996;88:657-666. [Free Full Text]
  15. Tamaru J, Hummel M, Zemlin M, Kalvelage B, Stein H. Hodgkin's disease with a B-cell phenotype often shows a VDJ rearrangement and somatic mutations in the VH genes. Blood 1994;84:708-715. [Free Full Text]
  16. Kuppers R, Rajewsky K, Zhao M, et al. Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development. Proc Natl Acad Sci U S A 1994;91:10962-10966. [Free Full Text]
  17. Stoler MH, Nichols GE, Symbula M, Weiss LM. Lymphocyte predominance Hodgkin's disease: evidence for a kappa light chain-restricted monotypic B-cell neoplasm. Am J Pathol 1995;146:812-818. [Abstract]
  18. Hell K, Hansmann ML, Pringle JH, Lauder I, Fischer R. Combination of Hodgkin's disease and diffuse large cell lymphoma: an in situ hybridization study for immunoglobulin light chain messenger RNA. Histopathology 1995;27:491-499. [Medline]
  19. Schmid C, Sargent C, Isaacson PG. L and H cells of nodular lymphocyte predominant Hodgkin's disease show immunoglobulin light-chain restriction. Am J Pathol 1991;139:1281-1289. [Abstract]
  20. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994;84:1361-1392. [Free Full Text]
  21. Kanzler H, Küppers R, Hansmann ML, Rajewsky K. Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells.J Exp Med 1996;184:1495-505.
  22. Hummel M, Ziemann K, Lammert H, Pileri S, Sabattini E, Stein H. Hodgkin's disease with monoclonal and polyclonal populations of Reed-Sternberg cells. N Engl J Med 1995;333:901-906. [Free Full Text]
  23. Marks JD, Tristem M, Karpas A, Winter G. Oligonucleotide primers for polymerase chain reaction amplification of human immunoglobulin variable genes and design of family-specific oligonucleotide probes. Eur J Immunol 1991;21:985-991. [Medline]
  24. Ramasamy I, Brisco M, Morley A. Improved PCR method for detecting monoclonal immunoglobulin heavy chain rearrangement in B cell neoplasms. J Clin Pathol 1992;45:770-775. [Free Full Text]
  25. Hummel M, Tamaru J, Kalvelage B, Stein H. Mantle cell (previously centrocytic) lymphomas express VH genes with no or very little somatic mutations like the physiologic cells of the follicle mantle. Blood 1994;84:403-407. [Free Full Text]
  26. Cook GP, Tomlinson IM. The human immunoglobulin VH repertoire. Immunol Today 1995;16:237-242. [CrossRef][Medline]
  27. Foss HD, Herbst H, Oelmann E, et al. Lymphotoxin, tumour necrosis factor and interleukin-6 gene transcripts are present in Hodgkin and Reed-Sternberg cells of most Hodgkin's disease cases. Br J Haematol 1993;84:627-635. [Medline]
  28. Roth J, Daus H, Trumper L, Gause A, Salamon-Looijen M, Pfreundschuh M. Detection of immunoglobulin heavy-chain gene rearrangement at the single-cell level in malignant lymphomas: no rearrangement is found in Hodgkin and Reed-Sternberg cells. Int J Cancer 1994;57:799-804. [Medline]
  29. Pascual V, Liu YJ, Magalski A, de Bouteiller O, Banchereau J, Capra JD. Analysis of somatic mutation in five B cell subsets of human tonsil.J Exp Med 1994;180:329-39.
  30. Rajewsky K. Clonal selection and learning in the antibody system. Nature 1996;381:751-758. [CrossRef][Medline]
  31. Hansmann ML, Fellbaum C, Hui PK, Moubayed P. Progressive transformation of germinal centers with and without association to Hodgkin's disease. Am J Clin Pathol 1990;93:219-226. [Medline]
  32. Sundeen JT, Cossman J, Jaffe ES. Lymphocyte predominant Hodgkin's disease nodular subtype with coexistent "large cell lymphoma": histological progression or composite malignancy? Am J Surg Pathol 1988;12:599-606. [Medline]
  33. Ree HJ, Neiman RS, Martin AW, Dallenbach F, Stein H. Paraffin section markers for Reed-Sternberg cells: a comparative study of peanut agglutinin, Leu-M1, LN-2, and Ber-H2. Cancer 1989;63:2030-2036. [Medline]
  34. Falini B, Bigerna B, Pasqualucci L, et al. Distinctive expression pattern of the BCL-6 protein in nodular lymphocyte predominance Hodgkin's disease. Blood 1996;87:465-471. [Free Full Text]

 

This Article
-Abstract
- PDF

Commentary
-Letters

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation

Related Letters:

L&H Cells in Lymphocyte-Predominant Hodgkin's Disease
Küppers R., Rajewsky K., Braeuninger A., Hansmann M.-L., Hummel M., Stein H., Marafioti T., Anagnostopoulos I.
Extract | Full Text  
N Engl J Med 1998; 338:763-765, Mar 12, 1998. Correspondence

This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.